Shlomit Yust-Katz, Diane Liu, Ying Yuan, Vivien Liu, Sanghee Kang, Morris Groves, Vinay Puduvalli, Victor Levin, Charles Conrad, Howard Colman, Sigmonid Hsu, W. K. Alfred Yung and Mark R. Gilbert Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastoma Cancer 119
Version of Record online: 30 APR 2013 | DOI: 10.1002/cncr.28031
Lonafarnib, an oral selective farnesyltransferase inhibitor, can be safely combined with temozolomide. This combination is effective in patients with recurrent glioblastoma.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field